| Entry |
|
| Name |
Arotinolol hydrochloride (JP16);
Almarl (TN)
|
| Formula |
C15H21N3O2S3. HCl
|
| Exact mass |
407.0563
|
| Mol weight |
408.0021
|
| Structure |

     |
| Activity |
Antihypertensive
|
| Remark |
|
| Target |
|
| Pathway |
|
| Interaction |
|
| Structure map |
| beta-Adrenergic receptor agonists/antagonists |
|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
212 Antiarrhythmic agents
2123 Beta blockers
D01830 Arotinolol hydrochloride (JP16)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
alpha1-adrenergic receptor [HSA:146 147 148] [KO:K04137 K04136 K04135]
Arotinolol
D01830 Arotinolol hydrochloride (JP16)
beta1-adrenergic receptor [HSA:153] [KO:K04141]
Arotinolol
D01830 Arotinolol hydrochloride (JP16)
beta2-adrenergic receptor [HSA:154] [KO:K04142]
Arotinolol
D01830 Arotinolol hydrochloride (JP16)
beta3-adrenergic receptor [HSA:155] [KO:K04143]
Arotinolol
D01830 Arotinolol hydrochloride (JP16)
 |
| Other DBs |
CAS: 68377-91-3 PubChem: LigandBox: NIKKAJI: |
| KCF data |
 ATOM 24
1 C8x C 16.4881 -17.5839
2 C8y C 16.9242 -16.2521
3 S2x S 15.7875 -15.4255
4 C8y C 14.6509 -16.2521
5 C8x C 15.0869 -17.5839
6 C8y C 18.2573 -15.8211
7 N5x N 19.3941 -16.6555
8 C8y C 20.5288 -15.8335
9 S2x S 20.0976 -14.5004
10 C8x C 18.6964 -14.4983
11 S2a S 21.7320 -16.5224
12 C1b C 22.9421 -15.8218
13 C1c C 24.1522 -16.5152
14 C1b C 25.3623 -15.8146
15 N1b N 26.5725 -16.5083
16 C1d C 27.7826 -15.8077
17 C1a C 28.9927 -16.5011
18 O1a O 24.1553 -17.9164
19 C1a C 28.9927 -15.0999
20 C5a C 13.3176 -15.8209
21 O5a O 13.0245 -14.4508
22 N1a N 12.2777 -16.7600
23 C1a C 27.7826 -14.4077
24 X Cl 32.0640 -16.1755
BOND 24
1 8 11 1
2 5 1 1
3 11 12 1
4 12 13 1
5 2 6 1
6 13 14 1
7 14 15 1
8 1 2 2
9 15 16 1
10 2 3 1
11 16 17 1
12 3 4 1
13 13 18 1
14 6 7 1
15 16 19 1
16 7 8 2
17 8 9 1
18 4 20 1
19 9 10 1
20 20 21 2
21 10 6 2
22 20 22 1
23 4 5 2
24 16 23 1
|